{"id":"W4234971132","doi":"10.2165/00128415-200510380-00011","title":"Apotex updates Canadian Apo-Mefloquine patient leaflet","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Mefloquine; Leaflet (botany); Pharmacology; Medicine; Biology; Malaria; Immunology; Chloroquine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007957117,0.0005431232,0.0006007302,0.0008199477,0.001545258,0.001376859,0.0008016767,0.005545732,0.1735396],"category_scores_gemma":[0.005343841,0.0002750462,0.0005935104,0.00047917,0.0003189092,0.0005122503,0.0005314065,0.003060204,0.03414774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002903101,"about_ca_system_score_gemma":0.004257909,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05826589,"about_ca_topic_score_gemma":0.2040056,"domain_scores_codex":[0.999449,0.00005193688,0.00003532865,0.00002194258,0.0003360563,0.0001056322],"domain_scores_gemma":[0.9952507,0.0008017685,0.0003249692,0.000161906,0.002296828,0.001163777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005103684,0.00002411677,0.0001819843,0.00001970453,0.000001379807,0.0002011359,0.000004412485,0.0000136511,0.00007574871,0.00007800155,0.9867011,0.01264771],"study_design_scores_gemma":[0.00007879859,0.0000335471,0.001379461,0.00004670479,0.0000052029,0.0002890046,0.000020309,0.00007075326,0.00008853306,0.0001214389,0.9978592,0.000007065518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.007241276,0.005800469,0.001057268,0.3140908,0.1169327,0.0005967191,0.003976712,0.001730597,0.5485734],"genre_scores_gemma":[0.01580014,0.004453947,0.001813383,0.09256484,0.03831757,0.0001860436,0.001985428,0.000244158,0.8446347],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.9417341,"threshold_uncertainty_score":0.5805477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01496895102402561,"score_gpt":0.2930518241767922,"score_spread":0.2780828731527666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}